Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor
- 1 July 2023
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 318 (Pt A) , 116833
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolismJournal of Clinical Investigation, 2017
- Management of cholestatic disease in 2017Liver International, 2017
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic DiseaseGastroenterology, 2016
- The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and DiseaseCurrent Drug Targets, 2016
- Development of analytical method for simultaneous determination of five rodent unique bile acids in rat plasma using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometryJournal of Chromatography B, 2015
- Clinical application of transcriptional activators of bile salt transportersMolecular Aspects of Medicine, 2014
- Platycodin D attenuates bile duct ligation-induced hepatic injury and fibrosis in miceFood and Chemical Toxicology, 2013
- Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in miceHepatology, 2012
- Preparative enrichment and separation of astragalosides from Radix Astragali extracts using macroporous resinsJournal of Separation Science, 2010
- Bile acids: regulation of synthesisJournal of Lipid Research, 2009